Post by Microsphere

It’s time to explore the future of Pharma with Microsphere at Japan CPHI, from April 21-23. Microsphere facility operates under 𝐏𝐌𝐃𝐀 and 𝐅𝐃𝐀 𝐚𝐮𝐭𝐡𝐨𝐫𝐢𝐳𝐚𝐭𝐢𝐨𝐧𝐬, enabling manufacturers to develop and produce drug products suitable for both the Japanese and U.S. markets. This is a key advantage for companies looking to expand globally. Book a meeting with Andrea Tapparo to discuss how our expertise in particle engineering and drug delivery can support your next project. Send us an email 👉 [email protected] At Microsphere, we support pharmaceutical companies worldwide as a CDMO specialized in 𝐩𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐞𝐧𝐠𝐢𝐧𝐞𝐞𝐫𝐢𝐧𝐠, 𝐝𝐫𝐮𝐠 𝐩𝐫𝐨𝐝𝐮𝐜𝐭 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭, 𝐑&𝐃, 𝐒𝐩𝐫𝐚𝐲 𝐃𝐫𝐲𝐢𝐧𝐠 and 𝐂𝐚𝐩𝐬𝐮𝐥𝐞 𝐅𝐢𝐥𝐥𝐢𝐧𝐠. Our expertise in Spray Drying enables us to improve solubility, stability, and bioavailability of challenging APIs, helping partners overcome formulation hurdles and accelerate their development timelines. 𝐅𝐫𝐨𝐦 𝐞𝐚𝐫𝐥𝐲-𝐬𝐭𝐚𝐠𝐞 formulation and process development 𝐭𝐨 𝐆𝐌𝐏 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠, our integrated approach allows us to guide projects efficiently from concept to clinical and commercial production. 東京でお会いできるのを楽しみにしております #CPHI #CDMO #ContractManufacturing #Pharma #ParticleEngineering #Microsphere #CMO #CPHIJapan2026 #LifeSciences #DrugDevelopment #BioPharma #PharmaAsia #PMDA